Floatz logo

Fpv-Cv301

Non-small Cell Lung Cancer (NSCLC)

Bavarian NordicvaccinePhase 1Dormant
CC
42/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
31/ 100
Competitive Position
73/ 100

Competitive context

39 Active assets in the Non-small Cell Lung Cancer (NSCLC) cohort.

Asset / SponsorPhaseRating
Folate
Heather Wakelee
Phase 2CCC
Setidegrasib
Astellas Pharma Global Development, Inc.
Phase 3CCC
Daraxonrasib
Revolution Medicines, Inc.
Phase 1/2CCC
CABAZITAXEL
University of Alabama at Birmingham
Phase 2CCC
Naquotinib Mesilate
Astellas Pharma Global Development, Inc.
Phase 3CCC

View all 50 →

Same molecule, other indications

Fpv-Cv301 is also rated in:

Small Bowel CancersDormant
CCC
Indicative ·
52 / 100
View asset →
colorectal cancerDormant
CCC
Indicative ·
50 / 100
View asset →
Prostate CancerDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →